Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice : Pharmacogenetics and Genomics

Secondary Logo

Journal Logo

Original Articles

Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice

Sychev, Dmitry Alekseevitcha; Sokolov, Aleksey Vladimirovichb; Reshetko, Olga Vilorovnab; Fisenko, Vladimir Petrovichc; Sychev, Igor Nikolaevicha; Grishina, Elena Anatolievnad; Bochkov, Pavel Olegoviche; Shevchenko, Roman Vladimiroviche; Abdullaev, Sherzod Pardaboevichf; Denisenko, Natalia Pavlovnae; Ivashchenko, Dmitry Vladimirovichg; Sozaeva, Zhannet Alimovnah; Kachanova, Anastasia Alekseevnah

Author Information
Pharmacogenetics and Genomics 32(9):p 301-307, December 2022. | DOI: 10.1097/FPC.0000000000000483

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid